Endometrial cancer stage IV

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
PARP inhibitor 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Tesaro Inc. Commercial
    DOSTARLIMAB; NIRAPARIB TOSILATE MONOHYDRATE
    2023-506551-23-00 13 countries 2019 n=225
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Tesaro Inc. Commercial 1 Phase III 0
New trials by year
2019
1
← All indication landscapes